April 24, 2015 | Story Review

Potential harms missing in coverage of Color Genomics cancer test

The failure to discuss potential harms of more widespread testing in more than a general way is a significant omission in this story.

4 Star

Color Genomics Sells $249 Breast Cancer Gene Test to Masses

April 23, 2015 | News Release Review

Is this volunteer program really “reversing part of the aging process”?

While we love the concept of this study, this release ignores the overall negative findings of the research, and instead highlights results from a small group of men within the study.

3 Star

Study: Civic engagement may stave off brain atrophy, improve memory

April 22, 2015 | Story Review

Aspirin for cancer prevention: A few small details would make a big difference in this story

With some wording changes and a few more statistics, this pretty good story about aspirin for cancer prevention would have become demonstrably better.

3 Star

Aspirin May Help Ward Off Gastro Cancers, Study Finds

April 22, 2015 | Story Review

Story on new melanoma drug combo neglects to mention $250,000 price tag

This bare-bones report on a drug trial was probably aimed at investors — but will almost certainly reach consumers as well. We think both groups would be interested in the very high cost of this drug combination.

2 Star

Bristol-Myers immunotherapy combo promising in melanoma: study

Toolkit

Tips for Understanding Studies

View More

Toolkit

Story Reviews

Our team of reviewers applies 10 standardized criteria to news stories that include claims about health care interventions. ~2,000 reviews published.

Read More

News Release Reviews

We systematically evaluate the quality of health care-related news releases by journals, medical centers, drug/device makers, others.

Read More

Blog

Wide-ranging exploration of issues in journalism, journal publishing, health care PR, advertising and marketing. Some opinions - publisher Gary Schwitzer's & others'.

Read More